Combining generative artificial intelligence and on-chip synthesis for de novo drug design
Sign Up to like & getrecommendations! Published in 2021 at "Science Advances"
DOI: 10.1126/sciadv.abg3338
Abstract: Generative deep learning and miniaturized bench-top synthesis were combined to automate the design of novel LXR agonists. Automating the molecular design-make-test-analyze cycle accelerates hit and lead finding for drug discovery. Using deep learning for molecular… read more here.
Keywords: lxr agonists; drug; chip synthesis; synthesis ... See more keywords